Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Avastin
Avastin
Opportunities in Lung Cancer Therapies
Motley Fool
Sun, 11/24/13 - 12:30 pm
lung cancer
non-small cell lung cancer
Avastin
Genentech
Roche
Tarceva
AstraZeneca
Iressa
Alimta
selumetinib
Array Biopharma
CO-1686
Clovis Oncology
AP26113
Ariad Pharmaceuticals
Roche's Avastin boosts survival in advanced ovarian cancer
Pharma Times, UK
Tue, 10/22/13 - 08:15 am
Roche
ovarian cancer
Avastin
Germany's Merck sees long-term growth in cancer drug Erbitux
Yahoo/Reuters
Fri, 10/4/13 - 10:27 am
Erbitux
Merck KGaA
Avastin
colorectal cancer
Merck KGaA's Drug Tops Roche's Avastin for Colon Cancer
Bloomberg
Sat, 09/28/13 - 11:46 am
Merck KGaA
colon cancer
Roche
Avastin
Erbitux
Understanding the Massive Market Potential of Monoclonal Antibodies
Motley Fool
Wed, 08/28/13 - 04:53 pm
monoclonal antibodies
Roche
Herceptin
Rituxan
Avastin
GSK
Amgen
Eli Lilly
Bristol-Myers Squibb
Seattle Genetics
Adcetris
Kadcyla
bapineuzumab
Elan
JNJ
Pfizer
necitumumab
AbbVie
Humira
The 5 Best-Selling Medications of 2013 (So Far)
Motley Fool
Tue, 08/6/13 - 11:24 am
AbbVie
Humira
Advair
GSK
Seretide
Enbrel
Amgen
Pfizer
Lantus
Sanofi
Avastin
Roche
Roche's Avastin fails to prolong survival in brain cancer study
Reuters
Sun, 06/2/13 - 11:52 am
Roche
Avastin
glioblastoma
brain cancer
Erbitux Tops Roche’s Avastin for Colon Cancer Survival
Bloomberg
Sat, 06/1/13 - 12:42 pm
Erbitux
Roche
Avastin
colon cancer
Merck KGaA
Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players
Motley Fool
Mon, 05/6/13 - 09:12 am
kidney cancer
ONYX Pharmaceuticals
Bayer
Nexavar
Roche
Avastin
Inlyta
Sutent
Pfizer
Votrient
GSK
Afinitor
Novartis
BMS-936558
Bristol-Myers Squibb
tivozanib
Aveo Oncology
Tackling Cancer: Lung Cancer's Biggest Current and Upcoming Players
Motley Fool
Wed, 03/20/13 - 11:56 am
lung cancer
Roche
Avastin
Tarceva
Astellas
Pfizer
Xalkori
Celgene
Abraxane
Gemzar
Alimta
Eli Lilly
Italian antitrust agency probes alleged Roche-Novartis cartel
Fierce Pharma
Wed, 02/20/13 - 12:12 pm
Lucentis
Roche
Avastin
Italy
Novartis
antitrust
FDA approves new use for Roche's Avastin in colon cancer treatment
Reuters
Thu, 01/24/13 - 10:40 am
Roche
FDA
Avastin
colorectal cancer
Avastin Shows No Benefit for Earlier Colon Cancer: Study
Medine Plus
Thu, 12/13/12 - 11:52 am
Avastin
colon cancer
Roche
Roche says Avastin slows brain cancer tumor growth
Reuters
Fri, 08/10/12 - 06:24 pm
Avastin
Roche
glioblastoma
brain cancer
NICE turns down Avastin for breast cancer
Fierce Pharma
Fri, 07/6/12 - 11:20 am
Avastin
Roche
breast cancer
NICE
UK
ASCO '12: Colon Cancer Drugs Good (Roche) and Very Bad (Keryx Pharma)
The Street
Sun, 06/3/12 - 12:40 pm
colon cancer
Roche
Keryx
perifosine
Avastin
Avastin, Lucentis equally effective at improving vision, big study finds
Fierce Pharma
Tue, 05/1/12 - 12:39 pm
Lucentis
Avastin
Roche
Novartis
macular degeneration
On The Heels Of Chemo-Approved Cancer Drugs
Seeking Alpha
Mon, 04/30/12 - 10:13 am
Eli Lilly
Merck
Northwest Biotherapeutics
Roche
brain cancer
Temodar
Erbitux
DCVax
Avastin
Sanofi Loses Appeal in Roche Suit Over Rituxan, Avastin
Bloomberg
Fri, 03/23/12 - 11:30 am
lawsuits
Sanofi
Roche
Rituxan
Avastin
Genentech
Biogen Idec
Fake Avastin may not be the only counterfeit on doctors' shelves
Fierce Pharma
Thu, 02/16/12 - 11:44 am
Avastin
Roche
drug counterfeiting
Herceptin
Rituxan
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »